'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
- DOI
- 10.1016/j.canrad.2024.02.003
- Published
- 2024 Aug
- Container
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.canrad.2024.02.003,
title = {'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.},
author = {Mitrea D and Barbet N and Pacé-Loscos T and Scouarnec C and Ben-Dhia S and Baron D and Mineur L and Évesque L and Durand-Labrunie J and Gérard JP and Baudin G and Doyen J},
year = {2024},
journal = {Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique},
doi = {10.1016/j.canrad.2024.02.003},
url = {https://doi.org/10.1016/j.canrad.2024.02.003}
}RIS
TY - JOUR TI - 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study. AU - Mitrea D AU - Barbet N AU - Pacé-Loscos T AU - Scouarnec C AU - Ben-Dhia S AU - Baron D AU - Mineur L AU - Évesque L AU - Durand-Labrunie J AU - Gérard JP AU - Baudin G AU - Doyen J PY - 2024 JO - Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique DO - 10.1016/j.canrad.2024.02.003 UR - https://doi.org/10.1016/j.canrad.2024.02.003 ER -
APA
D, M., N, B., T, P., C, S., S, B., D, B., L, M., L, É., J, D., JP, G., G, B., & J, D. (2024). 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. https://doi.org/10.1016/j.canrad.2024.02.003
Source records
- pubmed · retrieved 2026-09-27T07:30:20.312Z